ARCHIVES

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

This article is from The Cancer Letter archive.

Vol. 17 No. 36 | September 20, 1991

Download PDF Visit The Full Archive

Related Articles

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

NCI Seeks CRADA Partners To Develop Targets Drugs

October 24, 1997

In Brief: Nominations Open For Bristol-Myers Award; New Surgical Oncology Chair At South Florida

September 7, 1984

Some Cancer Control Projects On Thin Ice As Board Eyes Funds For Others

January 29, 1982

Funding Opportunities: NCI Schedules Meeting on RFA For Pathology Informatics

May 12, 2000